References
- BafadhelMPavordIDRussellREKEosinophils in COPD: just another biomarker?Lancet Respir Med20175974775928601554
- WatzHTetzlaffKWoutersEFBlood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialLancet Respir Med20164539039827066739
- PavordIDChanezPCrinerGJMepolizumab for eosinophilic chronic obstructive pulmonary diseaseN Engl J Med2017377171613162928893134
- KarchAVogelmeierCWelteTThe German COPD cohort COSYCONET: aims, methods and descriptive analysis of the study population at baselineRespir Med2016114273727109808
- HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- OshagbemiOABurdenAMBraekenDCWStability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline countsAm J Respir Crit Care Med2017195101402140428165763
- SinghDKolsumUBrightlingCEEosinophilic inflammation in COPD: prevalence and clinical characteristicsEur Respir J20144461697170025323230